TEACHERS ADVISORS, LLC - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 105 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 56.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q1 2019$3,529,000
-10.3%
155,690
+1.2%
0.00%
-33.3%
Q4 2018$3,935,000
-56.9%
153,769
-45.0%
0.01%0.0%
Q3 2018$9,136,000
+272.1%
279,630
+158.3%
0.01%
+100.0%
Q2 2018$2,455,000
-4.1%
108,263
+2.5%
0.00%0.0%
Q1 2018$2,561,000
-10.7%
105,605
+2.7%
0.00%
-25.0%
Q4 2017$2,867,000
-18.5%
102,788
+0.0%
0.00%
-20.0%
Q3 2017$3,518,000
-14.6%
102,757
-0.6%
0.01%
-16.7%
Q2 2017$4,118,000
+39.6%
103,358
+29.0%
0.01%
+50.0%
Q1 2017$2,950,000
+33.0%
80,113
+15.2%
0.00%
+33.3%
Q4 2016$2,218,000
+4.9%
69,563
+19.2%
0.00%
-25.0%
Q3 2016$2,115,000
+59.7%
58,3620.0%0.00%
+100.0%
Q2 2016$1,324,000
+41.3%
58,362
+17.1%
0.00%0.0%
Q1 2016$937,000
+23.0%
49,857
+7.2%
0.00%
+100.0%
Q4 2015$762,000
+85.0%
46,489
+23.9%
0.00%0.0%
Q3 2015$412,000
-15.6%
37,5080.0%0.00%0.0%
Q2 2015$488,000
-14.5%
37,508
+13.9%
0.00%0.0%
Q1 2015$571,000
+16.3%
32,9200.0%0.00%0.0%
Q4 2014$491,000
-35.3%
32,9200.0%0.00%
-50.0%
Q3 2014$759,000
-27.6%
32,9200.0%0.00%0.0%
Q2 2014$1,049,00032,9200.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 7,012,226$60,515,5108.59%
Irenic Capital Management LP 2,760,948$23,826,9816.76%
Newtyn Management, LLC 1,841,560$15,892,6633.92%
Weiss Asset Management LP 7,457,060$64,354,4283.81%
Park West Asset Management LLC 1,983,251$17,115,4561.57%
Baupost Group 7,419,226$64,0281.23%
Oasis Management Co Ltd. 953,254$8,226,5820.36%
Chescapmanager LLC 287,333$2,479,6840.32%
GSA CAPITAL PARTNERS LLP 325,985$2,8130.24%
Virtus ETF Advisers LLC 29,232$252,2720.15%
View complete list of THERAVANCE BIOPHARMA INC shareholders